Aptimmune Biologics is creating valuable, safe, and effective mucosal vaccines to combat economically challenging swine diseases. Aptimmune Biologics specializes in developing revolutionary mucosal vaccines that provide unsurpassed efficacy against the viral diseases most costly to the swine industry and the prevention of two major diseases – Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza.

For more information, visit Aptimmune Biologics or follow their updates on: